Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CFAP20 (Cilia and flagella associated protein 20) is a structural protein localized within the axoneme of cilia and flagella, particularly at the inner junction between the A and B tubules of microtubule doublets[1][2][3]. It is essential for the organization and structural integrity of both motile and non-motile cilia, functioning as a microtubule inner protein (MIP) and scaffolding complex components involved in the regulation of ciliary and flagellar motility and morphology[1][2][3]. Mutations in CFAP20 disrupt axonemal structure, causing abnormalities in ciliary function, which leads to clinical manifestations including inherited retinal dystrophy and other ciliopathies in humans and animal models[2][3]. CFAP20’s activity also involves regulation of protein polyglutamylation, and it is implicated in sensory signaling, organismal development, and regulation of specific behaviors such as feeding[2][3]. While it has not been defined as a therapeutic drug target or receptor, it serves as a key structural and functional protein for understanding cilia-related diseases[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cilia and flagella associated protein 20 (CFAP20).